23.1 C
Washington
Friday, October 7, 2022

From the very beginning of the epidemic, Moderna was under the impression that BioNTech was infringing on their patent

Stephane Bancel, the Chief Executive Officer of Moderna Inc., said on Wednesday that the company had suspected BioNTech SE of using its intellectual property in the production of a competing vaccine from the beginning of the Covid-19 outbreak.

Last month, Moderna filed a lawsuit alleging that BioNTech and its partner, Pfizer Inc., infringed upon its patents throughout the process of developing the first vaccination for Covid-19 to be licenced for use in the United States.

While in Tokyo, Bancel said that Moderna is contemplating constructing production facilities in Japan in order to manufacture mRNA-derived goods.

Jonathan James
I serve as a Senior Executive Journalist of The National Era
Latest news
Related news

LEAVE A REPLY

Please enter your comment!
Please enter your name here